The US Centers for Disease Control and Prevention (CDC) today reported three new infections involving novel influenza A viruses, two of them variant H3N2 (H3N2v) and one variant H1N2 (H1N2v), with possible human-to-human transmission in one of the cases.
CARB-X announced today that it's awarding $168,000 to Integrated Biotherapeutics to develop a vaccine for the prevention of infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
CARB-X, an initiative to build a better pipeline of new antibiotics for treating resistant infections, announced today that it awarded Inhibrx $4.55 million to speed up the development of a new antibody to prevent and treat Pseudomonas, a hard-to-treat Gram-negative pathogen often found in health settings.
European health and food safety agencies have established a set of indicators to assess progress in combating antimicrobial resistance (AMR) and reducing antimicrobial use in humans and food-producing animals.
Alopexx Vaccine LLC today reported positive phase 1 results for its broad-spectrum antimicrobial vaccine, which targets drug-resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and serious infections like pneumonia, meningitis, bloodstream infections, and gonorrhea.
The technique could be used to detect outbreaks while they're happening.
An antimicrobial stewardship program (ASP) at a long-term acute care hospital in Detroit improved antimicrobial prescribing practices, reduced costs, and has proven to be sustainable, researchers report today in the American Journal of Infection Control.
Three studies presented at IDWeek 2017 in San Diego last week focused on the emerging colistin-resistance gene MCR-1 in the United States.
Iranian scientists report a 7.6% prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in almost 500 hospital food samples they tested, and the bacteria had high levels of resistance to other antibiotics, as well, according to a study yesterday in Antimicrobial Resistance & Infection Control.
The Saudi Arabian Ministry of Health (MOH) reported two new cases of MERS-CoV in Al Hofuf late last week, one of which was fatal. These are the first cases reported by the MOH in 10 days.
On Sep 21, the MOH confirmed that a 48-year-old Saudi man with direct camel contact was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus) infection after presenting with MERS symptoms. He is in stable condition.
